Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 double-blind placebo-controlled varenicline trial for smoking cessation in patients with depression
2009-014916-37Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing varenicline with placebo (2 arms). Primary endpoint: 4-week Continuous Quit Rate (Weeks 9-12). Started Jan 2010; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2009-014916-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014916-37.